Johnson & Johnson (JNJ) Cash from Financing Activities (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Cash from Financing Activities data on file, last reported at $530.0 million in Q1 2026.

• Quarterly Cash from Financing Activities fell 94.91% year-over-year to $530.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15.4 billion (down 328.81% YoY) and the FY2025 annual result came in at -$5.5 billion, down 76.85% from the prior year.
• Cash from Financing Activities improved to $530.0 million in Q1 2026 per JNJ's latest filing, from -$1.4 billion in the prior quarter.
• The five-year high for Cash from Financing Activities was $10.4 billion in Q1 2025, with the low at -$11.3 billion in Q4 2023.
• Average Cash from Financing Activities over 5 years is -$1.8 billion, with a median of -$1.4 billion recorded in 2025.
• Year-over-year, Cash from Financing Activities sank 367.53% in 2023 and soared 1808.79% in 2025.
• Johnson & Johnson's Cash from Financing Activities stood at -$4.4 billion in 2022, then dropped by 6.16% to -$4.7 billion in 2023, then soared by 71.21% to -$1.3 billion in 2024, then slipped by 2.16% to -$1.4 billion in 2025, then jumped by 138.71% to $530.0 million in 2026.
• Business Quant data shows JNJ's Cash from Financing Activities at $530.0 million in Q1 2026, -$1.4 billion in Q4 2025, and -$8.9 billion in Q3 2025.